Drug · DIN 02515504
INPROSUB
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since June 13, 2024.
- Drug Identification Number (DIN)
- 02515504
- Company (DIN owner)
- Ibsa Institut Biochimique SaPazzallo, --, Switzerland
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Progesterone G03DA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROGESTERONE | 25 MG | 1.112 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 30, 2021: NOC 25767New Drug Submission (NDS)